SCHEMBL8910450

SCHEMBL8910450

CC(=O)OCc1c(C(C)=O)c(C)c(C(=O)OCc2ccccc2)n1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
RAB9A P51151 6/20 0.51
NPC1 O15118 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
MAPT P10636 4/20 0.45
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 1/20 0.41
STAT1 P42224 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GAA P10253 1/20 0.39
IDH1 O75874 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8911150 0.85 RAB9A (0.57) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
SCHEMBL8910153 0.83 KMT2A (0.56) ALDH1A1RAB9ANPC1SMN1; SMN2KMT2A
E1501 SCHEMBL27585125 0.75 ALDH1A1 (0.96) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
E1501 SCHEMBL28201296 0.73 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
E1501 SCHEMBL901210 0.73 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
E1501 SCHEMBL14031569 0.73 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
E1501 SCHEMBL43745 0.73 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
SCHEMBL20154166 0.72 KMT2A (0.54) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
SCHEMBL17965761 0.72 TDP1 (0.61) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1
E1501 SCHEMBL183528 0.72 ALDH1A1 (0.96) ALDH1A1RAB9ANPC1SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed